China Pharma Reports Sharp Rise In Q3 Profits, Driven In Part By Beijing's Health Reforms
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Benefiting from an expanded distribution network and better marketing, specialty pharmaceutical manufacturer China Pharma reported a 23.1 percent jump in third-quarter revenue for this year